Ownership history in WINTON GROUP Ltd · 36 quarters on record
This page tracks every 13F SEC filing in which WINTON GROUP Ltd reported a position in UNITED THERAPEUTICS CORP DEL (UTHR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 21,109 | +20,074 | +1939.5% | 0.33% | $8.8M | $419.21 |
| 2023 Q4 | REDUCED | 1,035 | -770 | -42.7% | 0.02% | $228K | $219.89 |
| 2023 Q3 | ADDED | 1,805 | +309 | +20.7% | 0.03% | $408K | $225.87 |
| 2023 Q2 | REDUCED | 1,496 | -9,967 | -86.9% | 0.03% | $330K | $220.75 |
| 2023 Q1 | REDUCED | 11,463 | -1,784 | -13.5% | 0.16% | $2.6M | $223.96 |
| 2022 Q4 | REDUCED | 13,247 | -5,645 | -29.9% | 0.24% | $3.7M | $278.09 |
| 2022 Q3 | ADDED | 18,892 | +817 | +4.5% | 0.26% | $4.0M | $209.38 |
| 2022 Q2 | ADDED | 18,075 | +2,071 | +12.9% | 0.23% | $4.3M | $235.64 |
| 2022 Q1 | ADDED | 16,004 | +5,641 | +54.4% | 0.15% | $2.9M | $179.41 |
| 2021 Q4 | ADDED | 10,363 | +1,910 | +22.6% | 0.14% | $2.2M | $216.08 |
As of 2025 Q4 — sorted by position size